High Intensity Interval Training and Muscle Adaptations During PR
NCT ID: NCT05858463
Last Updated: 2023-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2023-09-30
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Few data have ascertained the benefit of HIIT on mitochondrial oxidative capacity (Vmax) in healthy subjects compared to continuous exercise training but no data are available in COPD patients with exercise-induced desaturation, and the change in oxidative stress in such training regimen.
The investigators hypothesize that the repetitive bursts of oxidative stress and the improved antioxidant capacity in the course of the training sessions would stimulate mitochondrial adaptations to a larger extent after HIIT than continuous exercise training in severe COPD patients with hypoxemia. Moreover, they will assess the relationship between the change in oxidative stress in blood and in muscle. The clinical relevance of this study will be to ascertain the benefit and the safety of HITT in this subgroup of COPD patients in whom benefit of PR is often weak.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise in Health and Chronic Obstructive Pulmonary Disease
NCT02300064
Pulmonary Adaptive Responses to HIIT in COPD
NCT05552833
Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD
NCT02074813
Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program
NCT03704935
Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia
NCT03092622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. A cycling endurance test performed until exhaustion CG: exercise at 75% of predetermined maximal workload (Wmax) IG: 1 min at Wmax followed with 1 min unloaded pedaling, up to a maximal duration of 30 minutes. During this test, oxygen consumption, minute ventilation, cardiac output (thoracic impedance), pulse oxygen saturation and muscle oxygen saturation (NIRS) will be recorded continuously.
Markers of oxidative stress will be measured before and at the end of the cycling test (5 ml blood).
2. The mitochondrial oxidative capacity of the quadriceps will be measured on a separate day. A 20 mg biopsy of the vastus lateralis will be obtained under local anaesthesia using a biopsy needle. Maximal mitochondrial oxygen consumption (Vmax) will be measured on fresh permeabilized fibers (10 mg) using high resolution respirometry (Oroboros®), and 10 mg will be frozen for determination of oxidative markers. Vmax was also determined non invasively by the recovery of muscle oxygen saturation (NIRS) during repetitive brief arterial occlusions (according to the method described by Ryan and coll).
As part of PR, the participants will complete 20 sessions of exercise training (HIIT or continuous). The exercise intensity will be adapted weekly according to the participant's sensation. In the IG, the sessions will not exceed 40 min (20 min of active exercise).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
High Intensity Interval training: 1 min at maximal workload followed by 1 min rest, repeated during a maximum of 40 min.
Modality of exercise training
muscle adaptations following intermittent high intensity interval exercise training and continuous low intensity exercise training
Control group
Low intensity continuous exercise training set at the level of the ventilatory threshold, lasting for a maximum of 40 min
Modality of exercise training
muscle adaptations following intermittent high intensity interval exercise training and continuous low intensity exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modality of exercise training
muscle adaptations following intermittent high intensity interval exercise training and continuous low intensity exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred for a pulmonary rehabilitation program
* Exercise-induced oxygen desaturation during a CardioPulmonary Exercise Test, defined as a decrease of oxygen saturation by pulse oximetry \>4% from resting value.
* Written informed consent
* Negative pregnancy test whenever applicable.
Exclusion Criteria
* Physical or psychological inability to perform exercise tests
* Life-threatening cardiac events contra-indicating exercise training
* Anticoagulant treatment (muscle biopsy)
* Pregnant or breastfeeding womenFemmes
* Subject with curator, deprived of freedoms or in safeguard of justice
* Non covered by the french social security system
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric Costes
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02468-35
Identifier Type: OTHER
Identifier Source: secondary_id
AOI 2022 COSTES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.